RituxiMab INDuction in Renal Transplantation
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Study ID
- NCT01095172
- Phase
- PHASE4
- Status
- Unknown
Conditions
- Function of Renal Transplant
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Rituximab — DRUG375mg/m\^2, single dose given 2-4 weeks prior to transplantation
- Tacrolimus — DRUGdose calculated to give levels of 3-7ng/ml
- Mycophenylate mofetil — DRUGMycophenylate mofetil 2g/day in divided doses
- Hydrocortisone — DRUG100mg hydrocortisone on the evening of the day of surgery and 2 further doses of hydrocortisone on day 1 post transplant.
- Prednisolone — DRUGPrednisolone 0.3mg/kg on day 2, 0.25mg/kg on day 3, 0.2mg/kg on day 4 and 0.16mg/kg on day 5. On day 6 they will receive 5mg prednisolone, and on day 7 none.
- Prednisolone — DRUGReducing dose of prednisolone over at least 6 months. Subsequent steroid maintenance or withdrawal will be at the discretion of the patient's clinician.
Study Details
Hypothesis: * That B cell depletion, rather than reducing acute rejection, will allow minimisation of immunosuppression, which may lead to better graft survival. Aim: * To assess whether the addition of rituximab to a low-dose tacrolimus immunosuppression regime allows a reduction in steroid administration. Objectives: * To assess whether B cell depletion affects graft function, acute rejection and complication rates * To assess whether the T cell response to allotransplantation is impaired by B cell depletion.
Key Dates
- Start date
- Nov 30, 2010
- Status verified
- Jul 2020
- Primary completion
- Oct 31, 2020
- Completion
- Oct 31, 2022
Study Design
- Enrollment
- 100 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: RituximabRituximab 375mg/m2 Low dose tacrolimus with mycophenylate mofetil, hydrocortisone and 1 week prednisolone
- Active Comparator: Control groupLow dose tacrolimus with mycophenylate mofetil and continued prednisolone
Primary Outcome Measure
Estimated GFR (calculated using the Cockcroft-Gault formula) [ Time Frame: 1 year ]